Telemedicine's Transformation of Oncology Care During, After the COVID-19 Pandemic: Dan Nardi, MS  AJMC

Reproxalap Receives Complete Response Letter From FDA for Use in Dry Eye Disease  AJMC

Care Coordination Engagement Patterns in Long-Term Patients  AJMC

Genetics and Environment Both Play a Role in Childhood Allergy Progression  AJMC

FINEARTS-HF Data Examine Finerenone Across Bilirubin Levels: Jawad Haider Butt, MD, PhD  AJMC

The Value of Newborn Screening for DMD: Barry Byrne, MD, PhD  AJMC

Aligning PBMs With Accessibility, Drug Cost Needs: JC Scott  AJMC

Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy  AJMC

Areas of Unmet Need Continue to Burden Patients With gMG  AJMC

Expert Insights | AJMC | Page 748  AJMC

Prior Authorizations and the Adverse Impact on Continuity of Care  AJMC

Deep Learning Tool Differentiates Keloids From Malignant Lesions Without Dermoscopy  AJMC

AI in Health Care: Closing the Revenue Cycle Gap  AJMC

American Journal of Managed Care News & Expert Insights | AJMC | Page 760  AJMC

Sotatercept Reduces Risk of Death, Transplant, or Hospitalization in Advanced PAH  AJMC

ZENITH Trial Findings Could Reshape PAH Treatment, Extending Sotatercept’s Reach  AJMC

New FINEARTS-HF Findings Provide Clarity on Balancing Risk and Benefit in HF, CKD  AJMC

AMCP's CEO Susan Cantrell Previews the Upcoming Conference  AJMC

All News  AJMC

All News  AJMC

Semaglutide Demonstrates Enhanced Walking Capacity in ACC.25 STRIDE Data  AJMC

Abelacimab Shows Unprecedented Bleeding Risk Reduction in Patients With Atrial Fibrillation  AJMC

Ticagrelor Antidote Bentracimab Safely Reverses Antiplatelet Effects in Phase 3 REVERSE-IT Trial  AJMC

FDA Approves Fitusiran for Reducing Bleeds in Patients With Hemophilia A/B  AJMC

AJMC’s IVBM: Driving the Future of Cancer Care: Minneapolis  registration.ajmc.com